Erythropoiesis

Introduction

• Erythropoiesis is the process of formation of red blood cells in the bone marrow.
• Red cells have a finite lifespan of approximately 120 days in circulation.
• New cells are continuously produced to replace those lost by aging, hemorrhage, or destruction.
• The bone marrow maintains a balance between production and loss of red cells.
• Normal red cell mass is about 26–32 milliliters per kilogram in males and 23–29 milliliters per kilogram in females.
• Regulation ensures adequate oxygen-carrying capacity of blood.

Sites And Stages Of Erythropoiesis

• Definition: Erythropoiesis is the process of formation of red blood cells and is a key part of hemopoiesis.

Stages of Erythropoiesis

• Erythropoiesis occurs in three stages: mesoblastic, hepatic, and medullary stages.

Mesoblastic Stage

• This is the earliest stage during embryonic life.
• Red cell formation occurs in the mesoderm of the yolk sac and body.
• Erythropoiesis during this stage is intravascular in nature.

Hepatic Stage

• This stage begins around the fifth week of gestation.
• The liver is the primary site, with contribution from the spleen.
• It continues as the dominant site during early fetal life.

Medullary Stage

• This stage begins around the fifth month of intrauterine life.
• Bone marrow gradually becomes the principal site of red cell production.
• Activity increases toward the end of fetal life and continues after birth.
• After birth, bone marrow remains the sole site under normal conditions.
• Extramedullary erythropoiesis in postnatal life indicates pathology.
• In children, most bones are active, but in adults activity is limited to axial skeleton.

Steps of Erythropoiesis

• Erythropoiesis proceeds through four main stages: stem cells, progenitor cells, precursor cells, and mature cells.
• Pluripotent hematopoietic stem cells differentiate into committed erythroid stem cells.
• These cells form progenitor cells, which further develop into precursor cells.
• Precursor cells mature into reticulocytes and finally into erythrocytes.
• During maturation, cell size progressively decreases.
• The nucleus becomes smaller, chromatin condenses, and the nucleus is eventually lost.
• Cytoplasmic staining changes from basophilic to polychromatophilic and then to acidophilic.
• This reflects a reduction in ribonucleic acid and increased hemoglobin synthesis.

Stem Cells

Pluripotent Stem Cells

• Pluripotent stem cells are primary cells that give rise to all blood cell lineages.
• They possess two key properties: self-renewal and differentiation.
• Self-renewal maintains a constant stem cell pool in the bone marrow.
• Differentiation allows formation of specialized progenitor cells.

Committed Stem Cell

• Committed stem cells arise from pluripotent stem cells.
• They are restricted to specific lineages, such as myeloid or lymphoid series.
• Myeloid stem cells generate erythroid, megakaryocytic, granulocytic, and monocytic cells.
• Erythroid stem cells further form progenitor cells.
• Important erythroid progenitors include burst-forming unit–erythroid and colony-forming unit–erythroid.
• These progenitors eventually develop into precursor cells and mature red blood cells.

Progenitor Cells

• Progenitor cells in erythropoiesis include burst-forming unit–erythroid and colony-forming unit–erythroid.
• Both arise from a common progenitor cell of myeloid lineage.
• Burst-forming unit–erythroid cells produce a large number of colony-forming unit–erythroid cells.
• Colony-forming unit–erythroid cells generate erythroid precursor cells.
• These precursors further differentiate into erythroblasts and eventually mature red cells.

Precursor Cells

• Precursor cells of erythropoiesis are morphologically identifiable cells called erythroblasts or normoblasts.
• These cells arise from progenitor cells and undergo progressive maturation in the bone marrow.
• Erythroblasts develop sequentially from pronormoblasts into early, intermediate, and late normoblasts.

Pronormoblast

• Pronormoblast is the earliest recognizable precursor in erythroid lineage.
• It is a large cell, measuring about 15–20 micrometers in diameter.
• The cytoplasm is scanty and intensely basophilic due to abundant ribonucleic acid.
• The nucleus is large, occupies most of the cell, and contains prominent nucleoli.
• Active mitosis is present, indicating rapid proliferation.
• Hemoglobin synthesis has not yet begun at this stage.

Early Normoblast (Basophilic Erythroblast)

• The early normoblast is slightly smaller, measuring 12–18 micrometers.
• It continues to undergo mitotic division.
• The cytoplasm remains deeply basophilic due to high ribonucleic acid content.
• The nucleus is large with condensed chromatin arranged in coarse clumps.
• Chromatin pattern may appear like radiating strands.
• Initial hemoglobin synthesis begins at this stage.
• As maturation progresses, cytoplasmic color gradually shifts due to increasing hemoglobin and decreasing ribonucleic acid.
• Nuclear size reduces, chromatin condenses further, and nucleoli disappear.
• Ultimately, the nucleus is extruded, forming a reticulocyte that matures into a red cell.

Intermediate Normoblast (Polychromatic Erythroblast)

• The intermediate normoblast develops after division of the early erythroblast.
• It is smaller, with a diameter of about 10–15 micrometers.
• Cytoplasm shows mixed staining due to increasing hemoglobin and decreasing ribonucleic acid.
• This mixed staining gives a characteristic polychromatic appearance.
• The nucleus is reduced in size and occupies about half of the cell.
• Chromatin appears in coarse clumps with a checkerboard pattern.
• Nucleoli are absent at this stage.
• Hemoglobin synthesis increases significantly.
• Mitotic activity is present but reduced compared to earlier stages.

Late Normoblast (Orthochromatic Erythroblast)

• The late normoblast is the final stage before reticulocyte formation.
• It is the smallest erythroblast, measuring about 7–12 micrometers.
• Cytoplasm becomes strongly eosinophilic due to high hemoglobin concentration.
• The cell appears similar to a mature red cell except for the nucleus.
• The nucleus becomes small, dense, and pyknotic.
• Chromatin is highly condensed and may show a characteristic pattern.
• Mitosis is absent at this stage.
• Hemoglobin synthesis is nearly complete.
• The nucleus is eventually extruded, forming a reticulocyte.

Mature Cells

Reticulocytes

• Reticulocytes are immediate precursors of mature red blood cells.
• They contain a full complement of hemoglobin and are slightly larger than erythrocytes.
• Residual ribonucleic acid forms a reticular network within the cytoplasm.
• This network represents remnants of intracellular organelles.
• It can be demonstrated using supravital stains.
• Limited hemoglobin synthesis continues in early reticulocytes.
• The normal reticulocyte count is about 0–1 percent of circulating red cells.

Erythrocytes

• Erythrocytes are the final mature cells in erythropoiesis.
• They are biconcave discs with an average diameter of approximately 7.5 micrometers.
• They lack nucleus and organelles, allowing efficient gas transport.

H4: Duration of Erythropoiesis

• The total duration of erythropoiesis is approximately 7 to 9 days.
• Differentiation from progenitor cells to reticulocytes takes about 5 to 7 days.
• Reticulocytes mature into erythrocytes within about 2 days in circulation.

Regulation Of Erythropoiesis

• Erythropoiesis is regulated to maintain optimal red cell mass and oxygen delivery.
• The rate of production adjusts according to tissue oxygen requirements.
• There is no fixed anatomical reservoir controlling red cell production in humans.

Feedback Controls

• Regulation occurs through functional feedback and end-product feedback mechanisms.

Functional Feedback

• Functional feedback arises from tissue demand for oxygen.
• Reduced oxygen supply, or hypoxia, stimulates increased red cell production.
• This response ensures adequate oxygenation of tissues.
• Erythropoietin is the key hormone mediating this feedback.
• It is produced mainly by the kidneys in response to hypoxia.
• Erythropoietin stimulates bone marrow to increase erythroid cell production.
• This mechanism maintains balance between oxygen demand and red cell mass.

End-product Feedback

• End-product feedback is influenced by substances released during red cell destruction.
• Increased hemolysis stimulates erythropoiesis, leading to marrow hyperplasia.
• This response is more marked in hemolytic anemia than in blood loss of similar severity.
• Reticulocytosis reflects enhanced marrow activity in such conditions.
• The exact mediators are unclear, but heme derivatives may stimulate erythroid production.

Factors Controlling Erythropoiesis

• Erythropoiesis is regulated by hormonal, dietary, and other physiological factors.

Hormonal Factors

Erythropoietin

• Erythropoietin is the principal hormone controlling red cell production.
• It is produced mainly by the kidneys in response to reduced oxygen availability.
• Hypoxia stimulates its release, increasing erythroid activity in bone marrow.
• Erythropoietin enhances proliferation and maturation of erythroid precursor cells.
• This hormonal control maintains adequate oxygen-carrying capacity of blood.

History

• In 1906, French Professor Dr Paul Carnot and his associates suggested that hypoxia generates humoral factor capable of stimulating red cell production. In 1950, Kurt Ressmann provided strong support for existence of a hormonal mechanism, and few years later, it was named as erythropoietin. In 1957, Jacobson and coworkers found that the erythropoietin is produced by kidney.

Table 12.1: Factors controlling erythropoiesis.

Category	Key Components
Hormonal factors	Erythropoietin, androgens, estrogen, thyroxine, anterior pituitary hormones, corticosteroids, interleukins
Dietary factors	Vitamin B12, folic acid, vitamin C, proteins, minerals such as iron, copper, cobalt, nickel
Other factors	Intrinsic factor, hypoxia, drugs, and other chemical influences

Source

• Erythropoietin is produced mainly by interstitial cells around peritubular capillaries in the kidney.
• The kidney contributes approximately 85 percent of total production.
• Minor amounts arise from juxtaglomerular and mesangial cells.
• The liver contributes about 15 percent, mainly via hepatocytes and Kupffer cells.
• Small quantities may also be produced in the brain, uterus, and oviduct.

Structure

• Erythropoietin is a glycoprotein composed of 165 amino acids.
• It contains four oligosaccharide chains essential for biological activity.
• The molecular weight is approximately 34,000 daltons.

Mechanism of Action

• Erythropoietin binds to specific receptors on erythroid cells.
• These receptors belong to the cytokine receptor family.
• Binding activates intracellular signaling pathways involving JAK2 kinase.
• This signaling promotes gene expression and cell survival.
• The mechanism is similar to other growth factor–mediated pathways.

Functions

• Erythropoietin stimulates proliferation of progenitor cells such as burst-forming and colony-forming erythroid cells.
• It accelerates the cell cycle and enhances mitotic activity.
• It promotes maturation of erythroblasts into functional cells.
• It increases hemoglobin synthesis during cell development.
• It supports differentiation of stem cells toward erythroid lineage.
• It facilitates early release of reticulocytes into circulation.

Regulation of Erythropoietin (Ep) Production

• Factors regulating Ep production can be divided into factors increasing and factors decreasing the production.

Factors that increase Ep production:

• Hypoxia is the most potent stimulus for erythropoietin production.
• Reduced oxygen delivery, anemia, and low blood volume enhance secretion.
• Chronic lung diseases also increase erythropoietin levels.
• Hormones such as epinephrine, norepinephrine, and androgens stimulate production.
• Thyroxine, prolactin, and adrenocorticotropic hormone also enhance erythropoiesis.
• High altitude induces secondary polycythemia through increased erythropoietin release.

Factors that decrease Ep production:

• Estrogen reduces erythropoietin production and suppresses marrow response.
• Certain drugs, such as adenosine antagonists, decrease hormone secretion.

Metabolism

• Erythropoietin is mainly metabolized in the liver.
• Its normal half-life is approximately 5 hours.
• Loss of carbohydrate components markedly shortens its half-life.

Interleukins and GM-CSF

Interleukin 1, 3 and 5

• Interleukins promote differentiation of stem cells into progenitor cells.
• Granulocyte–macrophage colony-stimulating factor stimulates formation of committed stem cells.

Androgens

• Androgens enhance erythropoiesis directly and by increasing erythropoietin levels.
• This explains higher red cell counts in males after puberty.

Estrogens

• Estrogen has an inhibitory effect on erythropoiesis.

Thyroxine, Cortisol and Growth Hormone

• Thyroxine increases erythropoietin production and metabolic activity.
• Growth hormone promotes proliferation and maturation of erythroid cells.
• Cortisol may produce mild increases in red cell count.

Dietary Factors

Iron

• ·  Iron is essential for synthesis of heme, the oxygen-binding component of hemoglobin.
• ·  Adequate iron supply is necessary for effective erythropoiesis.
• ·  Iron deficiency leads to reduced hemoglobin formation.
• ·  This results in microcytic hypochromic anemia with small, pale red cells.

Vitamin B₁₂ and Folic Acid

• ·  Vitamin B12 and folic acid are required for deoxyribonucleic acid synthesis in erythroid precursors.
• ·  Folic acid is converted to active tetrahydrofolate, which supports thymine formation.
• ·  Thymine is essential for normal DNA replication and cell division.
• ·  Deficiency of folate impairs nuclear maturation and arrests mitosis.
• ·  Vitamin B12 enables conversion of inactive folate to its active form.
• ·  Deficiency of vitamin B12 causes accumulation of inactive folate, known as the methyl trap.
• ·  Both deficiencies disrupt normal erythropoiesis and lead to abnormal cell development.
• ·  Ineffective maturation produces large precursor cells called megaloblasts in bone marrow.
• ·  These give rise to enlarged red cells, resulting in macrocytic anemia.

Protein

• Protein is required for synthesis of globin chains of hemoglobin.
• Deficiency of protein reduces hemoglobin formation and contributes to anemia.

Other Nutritional Factors

• Vitamin C enhances intestinal absorption of iron.
• Its deficiency can impair iron utilization and promote anemia.
• Trace minerals such as copper and cobalt support hemoglobin synthesis.
• Deficiency of these elements may also lead to anemia.

Other Factors

Intrinsic factor

• Intrinsic factor is secreted by gastric oxyntic cells along with hydrochloric acid.
• It is essential for absorption of vitamin B12 in the terminal ileum.
• Deficiency of intrinsic factor impairs vitamin B12 absorption.
• This results in pernicious anemia, a form of megaloblastic anemia.

Environmental Factors

Hypoxia

• Hypoxia increases erythropoiesis by stimulating erythropoietin production.
• It occurs at high altitude and in cardiac or respiratory disorders.
• Certain drugs and chemicals enhance red cell production.

H5: Drugs and Chemicals

• Catecholamines, cyclic adenosine monophosphate, cobalt salts, and thyroxine stimulate erythropoiesis.
• Products of red cell breakdown may also promote marrow activity.

H4: Effective vs Ineffective Erythropoiesis

• Effective erythropoiesis refers to production of viable red cells with normal lifespan.
• Most cells formed in bone marrow enter circulation and function normally.
• A small proportion of cells may be destroyed early under normal conditions.
• Ineffective erythropoiesis occurs when many developing cells are destroyed before maturation.
• Destruction may occur within bone marrow or soon after release.
• It is suspected when marrow shows erythroid hyperplasia but reticulocyte count remains normal or low.

Reticulocytes

Structure

• Reticulocytes are immature red cells present mainly in bone marrow, with a small fraction in circulation.
• They lack a nucleus but retain residual ribonucleic acid from precursor cells.
• This residual material forms a characteristic reticular network within the cytoplasm.
• The network represents remnants of ribosomes and other cytoplasmic structures.
• On staining with supravital dyes such as cresyl blue or new methylene blue, the network becomes visible.
• It appears as threads, clumps, or granular aggregates within the cell.
• These stains act on living cells, allowing visualization of intracellular remnants.
• Reticulocytes are slightly larger than mature erythrocytes.
• Mature red cells lack both nucleus and cytoplasmic ribonucleic acid.
• In certain pathological conditions, aggregated ribonucleic acid appears as basophilic stippling.
• These appear as discrete blue granules within the cytoplasm.
• Such findings indicate disturbed erythropoiesis or toxic injury.

Development

• Reticulocytes are formed in bone marrow from late normoblasts.
• The nucleus is extruded from the orthochromatic erythroblast to form a reticulocyte.
• These cells gradually lose mitochondria, ribosomes, and residual ribonucleic acid.
• Loss of organelles leads to transformation into mature erythrocytes.
• Approximately 1 percent of circulating red cells are replaced daily.
• A small number of reticulocytes enter circulation under normal conditions.
• Increased release of reticulocytes indicates enhanced erythropoiesis.
• Therefore, reticulocyte count serves as an index of marrow activity, especially in anemia.

Table 12.2: Differences between reticulocytes and red cells.

Feature	Reticulocytes	Erythrocytes
Size	Slightly larger (≈8 micrometers)	Smaller (≈7.5 micrometers)
Residual material	Ribonucleic acid present	Absent
Proportion	About 1 percent of red cells	Predominant circulating cells
Mean corpuscular hemoglobin concentration	Slightly lower	Higher
Hemoglobin content	Comparable	Comparable

Reticulocyte Count

• Reticulocyte count represents the proportion of immature red cells in circulation.
• Normal value in adults is about 0–1 percent of total red cells.
• In newborns, it ranges from 2–6 percent.
• The count declines during infancy and stabilizes at adult levels.

Reticulocyte Response

• Reticulocyte count is used to assess bone marrow response to anemia treatment.
• Increased count indicates active erythropoiesis and effective therapy.
• During treatment, immature cells are released earlier into circulation.
• This transient rise is termed reticulocyte response.
• It is commonly observed after treatment of iron deficiency anemia and vitamin B12 deficiency.
• A rising count suggests adequate substrate availability and marrow recovery.
• Failure of increase indicates ineffective erythropoiesis or inadequate treatment.

Alteration in Reticulocyte Count

Reticulocytosis

• Reticulocytosis refers to an increased reticulocyte count in blood.
• Physiologically, it occurs in newborns, infants, and at high altitude.
• Pathologically, it is seen in hemolytic anemia and acute blood loss.
• It also occurs during treatment of deficiency anemias.
• It indicates increased bone marrow activity and enhanced erythropoiesis.

Reticulocytopenia

• Reticulocytopenia indicates a decreased reticulocyte count and always suggests pathology.
• It occurs in aplastic anemia, hypothyroidism, hypopituitarism, and marrow failure states.

Leucoerythroblastic Reaction

• Leucoerythroblastic reaction refers to the presence of immature myeloid cells and nucleated red cells in blood.
• It reflects disruption of bone marrow architecture by infiltration or fibrosis.
• Common causes include myelofibrosis, metastatic malignancy, and severe anemia.

Reticulocyte Count in Ineffective Erythropoiesis

• In ineffective erythropoiesis, reticulocyte count may remain normal despite increased marrow activity.
• This suggests defective maturation and increased destruction of developing cells.

Reticulocyte Index

• Reticulocyte index is a corrected measure of erythropoietic activity.
• Reticulocyte percentage alone may be misleading in anemia.
• Absolute reticulocyte count is calculated as percentage multiplied by red cell count.
• The index adjusts reticulocyte percentage according to hematocrit.
• It provides a more accurate assessment of red cell production rate.
• Increased index indicates active erythropoiesis, while low values suggest reduced marrow response.